336 related articles for article (PubMed ID: 29434059)
1. Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues.
Mourya DT; Yadav PD; Khare A; Khan AH
Indian J Med Res; 2017 Oct; 146(4):459-467. PubMed ID: 29434059
[TBL] [Abstract][Full Text] [Related]
2. Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting.
Mourya DT; Yadav PD; Majumdar TD; Chauhan DS; Katoch VM
Indian J Med Res; 2014 Aug; 140(2):171-83. PubMed ID: 25297350
[TBL] [Abstract][Full Text] [Related]
3. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
Zaki AN
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Departures from Regulatory Requirements Identified During Inspections Conducted by the US Federal Select Agent Program, 2014-15.
Bjork A; Sosin DM
Health Secur; 2017; 15(6):587-598. PubMed ID: 29193983
[TBL] [Abstract][Full Text] [Related]
5. Framework for leadership and training of Biosafety Level 4 laboratory workers.
Le Duc JW; Anderson K; Bloom ME; Estep JE; Feldmann H; Geisbert JB; Geisbert TW; Hensley L; Holbrook M; Jahrling PB; Ksiazek TG; Korch G; Patterson J; Skvorak JP; Weingartl H
Emerg Infect Dis; 2008 Nov; 14(11):1685-8. PubMed ID: 18976549
[TBL] [Abstract][Full Text] [Related]
6. Biosafety Level 4 Laboratory User Training Program, China.
Xia H; Huang Y; Ma H; Liu B; Xie W; Song D; Yuan Z
Emerg Infect Dis; 2019 May; 25(5):. PubMed ID: 31002302
[TBL] [Abstract][Full Text] [Related]
7. The Main Biological Hazards in Animal Biosafety Level 2 Facilities and Strategies for Control.
Li XY; Xue KN; Jiang JS; Lu XC
Biomed Environ Sci; 2016 Apr; 29(4):300-4. PubMed ID: 27241742
[TBL] [Abstract][Full Text] [Related]
8. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.
Joseph T; Phyu S; Se-Thoe SY; Chu JJH
Methods Mol Biol; 2022; 2452():441-464. PubMed ID: 35554920
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research Laboratories.
Homer LC; Alderman TS; Blair HA; Brocard AS; Broussard EE; Ellis RP; Frerotte J; Low EW; McCarthy TR; McCormick JM; Newton JM; Rogers FC; Schlimgen R; Stabenow JM; Stedman D; Warfield C; Ntiforo CA; Whetstone CT; Zimmerman D; Barkley E
Biosecur Bioterror; 2013 Mar; 11(1):10-9. PubMed ID: 23477631
[TBL] [Abstract][Full Text] [Related]
10. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R;
Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
[TBL] [Abstract][Full Text] [Related]
11. Standard practice for cell sorting in a BSL-3 facility.
Perfetto SP; Ambrozak DR; Nguyen R; Roederer M; Koup RA; Holmes KL
Methods Mol Biol; 2011; 699():449-69. PubMed ID: 21116997
[TBL] [Abstract][Full Text] [Related]
12. Establishing a national biological laboratory safety and security monitoring program.
Blaine JW
Biosecur Bioterror; 2012 Dec; 10(4):396-400. PubMed ID: 23210833
[TBL] [Abstract][Full Text] [Related]
13. A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan.
Muhammad J; Sarwar S; Khan T; Qasmi SA; Ikram A; Ahmad G; Zahid M; Durrani RH; Ahmed F
Front Public Health; 2021; 9():766162. PubMed ID: 34976925
[TBL] [Abstract][Full Text] [Related]
14. Laboratory Focus on Improving the Culture of Biosafety: Statewide Risk Assessment of Clinical Laboratories That Process Specimens for Microbiologic Analysis.
Munson E; Bowles EJ; Dern R; Beck E; Podzorski RP; Bateman AC; Block TK; Kropp JL; Radke T; Siebers K; Simmons B; Smith MA; Spray-Larson F; Warshauer DM
J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29118166
[TBL] [Abstract][Full Text] [Related]
15. [Biorisk Management for Clinical Diagnostic Laboratories].
Shigematsu M
Rinsho Byori; 2016 Nov; 64(11):1279-1289. PubMed ID: 30695310
[TBL] [Abstract][Full Text] [Related]
16. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
[TBL] [Abstract][Full Text] [Related]
17. Certification of TB culture and drug susceptibility testing laboratories through the Revised National Tuberculosis Control Programme (RNTCP).
Sachdeva KS; Nagaraja SB; Kumar A; Kumar P; Ramachandran R
J Indian Med Assoc; 2012 Jul; 110(7):488-9. PubMed ID: 23520677
[TBL] [Abstract][Full Text] [Related]
18. Validated Methods for Removing Select Agent Samples from Biosafety Level 3 Laboratories.
Kesterson AE; Craig JE; Chuvala LJ; Heine HS
Emerg Infect Dis; 2020 Nov; 26(11):2586-2590. PubMed ID: 33079040
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.
Kimman TG; Smit E; Klein MR
Clin Microbiol Rev; 2008 Jul; 21(3):403-25. PubMed ID: 18625678
[TBL] [Abstract][Full Text] [Related]
20. Practical biosafety in the tuberculosis laboratory: containment at the source is what truly counts.
van Soolingen D; Wisselink HJ; Lumb R; Anthony R; van der Zanden A; Gilpin C
Int J Tuberc Lung Dis; 2014 Aug; 18(8):885-9. PubMed ID: 25199000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
